- COVID-19: Essential market insight and resources
COVID-19: Essential market insight and resources
Navigate rapid market shifts with our expert data-driven insights and news.
As the COVID-19 pandemic continues to spread globally we are here to help you navigate extraordinary market challenges with our breadth and depth of expert data.
We are ever-ready to help you – our customers, partners, governments and media – understand the impact the pandemic is having on societies and economies. We have invested strongly in our business continuity and resilience measures and have ensured customers have complete remote access to our web-based products – to track, trade, advise and monitor markets at this pivotal moment.
Leverage Refinitiv's trusted data, market-leading insights and technology to navigate the rapid market shifts as you look for ways ahead - and count on our products to make sense of the unfolding financial crisis. Feel confident in the decisions you make with Refinitiv at your side.
How we can help
Track the global impact of Coronavirus with Eikon
To help navigate the markets with trusted and real-time data and insight on COVID-19, we have enhanced our products and curated insights.
Our Macro Vitals app provides a comprehensive set of data, news, charts and insight recording the economic impact of the coronavirus pandemic. Following the success of our Novel coronavirus and Macro Vitals Apps we decided to capture the best features of both Apps and combine them into one. This will make it easier for customers to access pandemic related information as well as extensive content and analytics on the impact that the virus is having on the global economy. Type ‘MACROV’ in Eikon to access the app.
Access Eikon through a web browser for optimal connection to our industry leading market data, news and content. This access point is lighter on memory capacity and hence, more adaptable for laptops or personal computers. Customers can access Eikon Web now with existing user credentials or contact us for complimentary access.
Not an Eikon user? Get in touch with us for complimentary access.
Watch the latest episode
The content and information (“Content”) in the video programs (“Video Programs”) is provided for informational purposes only and not investment advice. You should not construe any such Content, information or other material as legal, tax, investment, financial, or other professional advice nor does any such information constitute a comprehensive or complete statement of the matters discussed. None of the Content constitutes a solicitation, recommendation, endorsement, or offer by Refinitiv or any third party service provider to buy or sell any securities or other financial instruments in this or in any other jurisdiction in which such solicitation or offer would be unlawful under the securities laws of such jurisdiction. All Content is information of a general nature, is illustrative only and does not address the circumstances of any particular individual or entity. Refinitiv is not a fiduciary by virtue of any person’s use of or access to the Video Programs or Content. You alone assume the sole responsibility of evaluating the merits and risks associated with the use of any information or other Content in the Video Programs before making any decisions based on such information or other Content. In exchange for accessing and viewing the Video Programs and Content, you agree not to hold Refinitiv, its affiliates or any third party service provider liable for any possible claim for damages arising from any decision you make based on information or other Content made available to you through the Video Programs.
The Content and information in the Video Programs has been obtained from sources believed to be reliable, but Refinitiv makes no representation or warranty as to the accuracy, timeliness or completeness of the Content. Any opinion or recommendation expressed in the Video Programs is subject to change without notice. Refinitiv does not recommend, explicitly nor implicitly, nor suggest or recommend any investment strategy. Refinitiv disclaims all liability for any loss that may arise (whether direct, indirect, consequential, incidental, punitive or otherwise) from any use of the information in Video Programs. Refinitiv does not have regard to any individual’s, group of individuals’ or entity’s specific investment objectives, financial situation or circumstances. Refinitiv does not express any opinion on the future value of any security, currency or other investment instrument. You should seek expert financial and other advice regarding the appropriateness of the material discussed or recommended in the Video Programs and should note that investment values may fall, you may receive back less than originally invested and past performance is not necessarily reflective of future performance
Vaccines | Data Behind the Data
Published on: July 31, 2020 • Duration: 5 minutes
Louisa Bojesen and David Craig, Refinitiv’s CEO, talk about the data behind the data of vaccines. With scientists working around the clock to try to come up with a vaccine, many are questioning whether the gains seen in pharmaceutical companies will continue, especially given how long the average vaccine usually takes to be developed and taken to market.
Curated COVID-19 insights
Providing service continuity
We have invested strongly in our business continuity and resilience measures. Our top priority is the health of our people and our customers. We have control measures in place including business critical only travel restrictions. Refinitiv has well-established remote working capabilities which enable our employees to do their work and support our customers from anywhere in the world.
We continue to adhere to the highest possible standards issued by health experts at the World Health Organization (WHO), Centers for Disease Control (CDC) and Johns Hopkins Hospital, as well as governments and regulators across our 190 countries of operation.
Remote access information
We encourage customers to contact their IT department, where applicable, before downloading or accessing any of the following Refinitiv products in order to obtain approval or company guidance.
We're here for you
Have questions? We're here to help. Talk to a real person and get the answers that matter most.